Ireland
--:--IST
Active, not recruiting Phase 2

Evaluation Safety and Explore Efficacy Long-term Follow-up Study on Subjects Receiving SMUP-IA-01 or Active Control

NCT06798727 · tracked via the Priya Life Science South Korea tracker
Phase
Phase 2
Started
2023-03-20
Last updated
2025-02-07

Condition(s) studied

Knee Osteoarthritis

Investigational drug(s) / intervention(s)

SMUP-IA-01(low-dose)SMUP-IA-01(mid-dose)High Hyal Plus

SMUP-IA-01(low-dose): A single knee administration of SMUP-IA-01(low-dose, 4.0 x 10\^6 cells/2mL)

SMUP-IA-01(mid-dose): A single knee administration of SMUP-IA-01(mid-dose, 1.0 x 10\^7 cells/2mL)

High Hyal Plus: A single knee administration of Hyaluronic acid(1% Sodium Hyaluronate 20mg/2ml)

Study summary

This is a follow-up study to investigate the long-term safety and explore efficacy of SMUP-IA-01, for the treatment of Knee Osteoarthritis. Subjects who participated in and completed the initial stage of the Phase II trial (NCT05182034) will be followed-up until 60 months.

Eligibility

Sex
ALL
Min age
19 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Subject who completed the safety and explore efficacy evaluations in SMUP-IA-01 Phase II clinical trial. 2. Subject who voluntarily decided to participate and signed the consent form after receiving explanations on the clinical trial. Exclusion Criteria: 1. Subject who were not enrolled in phase II clinical trial of SMUP-IA-01 for assessing safety and explore efficacy. 2. Other subjects, excluding those listed above, who were deemed unsuitable by the PI

Primary outcome measure(s)

  • Change of total score in WOMAC (Western Ontario and McMaster University) — Time Frame: Month 12, 24, 36, 48 and 60 after treatment
    Comparing WOMAC total score changes with baseline scores of SMUP-IA-01 phase I trial and scores of f/u study at 12 months, 24 months, 36 months, 48 months and 60months after treatment (score range 0-96, higher score represent worse symptoms).

Trial sites (5)

FacilityCityRegionStatus
Seoul Nation University Bundang Hospital Gyeonggi-do South Korea
Gangnam Severance Hospital Seoul South Korea
Korea University Anam Hospita Seoul South Korea
Seoul National University Hospital Seoul South Korea
Severance Hospital Seoul South Korea
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06798727 on ClinicalTrials.gov ↗ ← All trials in South Korea